Health food product composition, structure and bioavailability

Designing Functional Foods: Measuring and Controlling Food Structure Breakdown and Nutrient Absorption

Volumn , Issue , 2009, Pages 647-675

  Duchateau, G S M J E ^a   Klaffke, W ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903256390     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845696603.3.647     Document Type: Chapter

References (85)

1. Ific Consumer Attitudes Toward Functional Foods/Foods for Health 2007, International Food Information Council, Washington.
2. Verschuren P.M. ILSI Europe Report Series. Functional Foods - Scientific and Global Perspectives 2002, Brussels.
3. Bellisle F. Functional foods in Europe - theme papers. British Journal of Nutrition 1998, 80:1-193.
4. Diplock A.T., Aggett P.J., Ashwell M., et al. Scientific concepts of functional foods in Europe consensus document. British Journal of Nutrition 1999, 81(4):S1-S27.
5. Regulation (EC) No. 1924/2006 of the European Parliament and of the Council of on nutrition and health claims made on foods; 2006.
6. Southon, S.; Model systems in vitro and in vivo, for predicting the bioavailability of lipid soluble components in food; Final Report FAIR CT97-3100; 2001.
7. Parada J., Aguilera J.M. Food microstructure affects the bioavailability of several nutrients. Journal of Food Science 2007, 72(2):R21-R32.
8. Title 21 - Food and Drugs Chapter I - Food and Drug Administration, Department of Health and Human Services - Continued Part 320 - Bioavailability and Bioequivalence Requirements; 21CFR320; 2000.
9. Food Chemicals Codex, 6th edn; United States Pharmacopeia, Rockville, MD; 2008.
10. Dressman J.B., Berardi R.R., Dermentzoglou L.C., et al. Upper gastrointestinal (GI) pH in young, healthy-men and women. Pharmaceutical Research 1990, 7(7):756-761.
11. Fallingborg J. Intraluminal pH of the human gastro-intestinal tract. Danish Medical Bulletin 1992, 46(3):183-196.
12. Chahinian H., Snabe T., Attias C., et al. How gastric lipase, an interfacial enzyme with a Ser-His-Asp catalytic triad, acts optimally at acidic pH. Biochemistry 2006, 45(3):993-1001.
13. Vertzoni M., Dressman J., Butler J., et al. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. European Journal of Pharmaceutics and Biopharmaceutics 2005, 60(3):413-417.
14. Kalantzi L., Goumas K., Kalioras V., et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharmaceutical Research 2006, 23(1):165-176.
15. Jantratid E., Janssen N., Reppas C., et al. Dissolution media simulating conditions in the proximal human gastro intestinal tract; an update. Pharmaceutical Research 2008, 25(7):1663-1676.
16. Armand M., Borel P., Pasquier B., et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. American Journal of Physiology - Gastrointestinal and Liver Physiology 1996, 34(1):G172-G183.
17. Stone B.G., Ansel H.J., Peterson F.J., et al. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology 1992, 15(5):795-798.
18. Froehlich F., Gonvers J.J., Fried M. Role of nutrient fat and cholescystokinin in regulation of gallbladder emptying in man. Digestive Diseases and Sciences 1995, 40(3):529-533.
19. Kossena G.A., Charman W.N., Wilson C.G., et al. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharmaceutical Research 2007, 24(11):2084-2096.
20. Priebe M.G., Wachters-Hagedoorn R.E., Stellaard F., et al. Oro-cecal transit time: influence of a subsequent meal. European Journal of Clinical Investigation 2004, 34(6):417-421.
21. Schiller C., Frohlich C.P., Giessmann T., et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Alimentary Pharmacology and Therapeutics 2005, 22(10):971-979.
22. Priebe M.G., Wachters-Hagedoorn R.E., Landman K., et al. Influence of a subsequent meal on the oro-cecal transit time of a solid test meal. European Journal of Clinical Investigation 2006, 36(2):123-126.
23. Hoad C.L., Marciani L., Foley S., et al. Non-invasive quantification of small bowel water content by MRI: a validation study. Physics in Medicine and Biology 2007, 52(23):6909-6922.
24. Sarker S.A., Davidsson L., Mahmud H., et al. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. American Journal of Clinical Nutrition 2004, 80:149-153.
25. Johnson K.C., Swindell A.C. Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharmaceutical Research 1996, 13(12):1795-1798.
26. Clarysse S., Tack J., Lammert F., et al. Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. Journal of Pharmaceutical Sciences 2009, 98(3):1177-1192.
27. Rigler M.W., Honkanen R.E., Patton J.S. Visualization by freeze fracture, in-vitro and in-vivo, of the products of fat digestion. Journal of Lipid Research 1986, 27(8):836-857.
28. Staggers J.E., Hernell O., Stafford R.J., et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase-behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human-beings. Biochemistry 1990, 29(8):2028-2040.
29. Hernell O., Staggers J.E., Carey M.C. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase-analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human-beings. Biochemistry 1990, 29(8):2041-2056.
30. Fennel Evans D., WennerstrÖM H. The Colloidal Domain; Where Physics, Chemistry, Biology and Technology Meet. 4.4 Micellar solution play a key role in many industrial and biological processes 1999, 198-216. VCH Publishers Inc, New York.
31. Patton J.S., Carey M.C. Watching fat digestion. Science 1979, 204(4389):145-148.
32. Kossena G.A., Charman W.N., Boyd B.J., et al. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. Journal of Pharmaceutical Sciences 2004, 93(2):332-348.
33. Persson E.M., Gustafsson A.-S., Carlsson A.M., et al. The effects of food on the dissolution of poorly soluble drugs in human and small intestinal fluids. Pharmaceutical Research 2005, 22(12):2141-2151.
34. Kaukonen A.M., Boyd B.J., Charman W.N., et al. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharmaceutical Research 2004, 21(2):254-260.
35. Kaukonen A.M., Boyd B.J., Porter C.J.H., et al. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharmaceutical Research 2004, 21(2):245-253.
36. Porter C.J.H., Pouton C.W., Cuine J.F., et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Advanced Drug Delivery Reviews 2008, 60:673-691.
37. Barthe L., Woodley J., Houin G. Gastrointestinal absorption of drugs: methods and studies. Fundamental and Clinical Pharmacology 1999, 13(2):154-168.
38. Hussain N., Jaitley V., Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Advanced Drug Delivery Reviews 2001, 50(1-2):107-142.
39. Lomer M.C.E., Hutchinson C., Volkert S., et al. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. British Journal of Nutrition 2004, 92(6):947-955.
40. Desai M.P., Labhasetwar V., Amidon G.L., et al. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharmaceutical Research 1996, 13(12):1838-1845.
41. Acosta E. Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Current Opinion in Colloid and Interface Science 2009, 14(1):3-15.
42. Hedren E., Diaz V., Svanberg U. Estimation of carotenoid accessibility from carrots determined by an in vitro digestion method. European Journal of Clinical Nutrition 2002, 56(5):425-430.
43. Kano M., Takayanagi T., Harada K., et al. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. Journal of Nutrition 2006, 136:2291-2296.
44. TM) in healthy volunteers. Advances in Therapy 2005, 22(1):65-78.
45. Decroos K., Eeckhaut E., Possemiers S., et al. Administration of equol-producing bacteria alters the equol production status in the simulator of the gastro-intestinal microbial ecosystem (SHIME). Journal of Nutrition 2006, 136:946-952.
46. Winiwarter S., Bonham N.M., Ax F., et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. Journal of Medicinal Chemistry 1998, 41(25):4939-4949.
47. Lennernas H. Human intestinal permeability. Journal of Pharmaceutical Sciences 1998, 87(4):403-410.
48. Anonymous; US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); Guidance for Industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Available from . http://www.fda.gov/cder/guidance/3618fnl.pdf.
49. Miret S., Abrahamse S.L., De Groene E.M. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. Journal of Biomolecular Screening 2004, 9(7):598-606.
50. Charman W.N.A., Stella V.J. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. International Journal of Pharmaceutics 1986, 34:175-178.
51. Mansbach C.M., Gorelick F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. American Journal of Physiology - Gastrointestinal and Liver Physiology 2007, 293(4):G645-G650.
52. Lipinski C.A., Lombardo F., Dominy B.W., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 1997, 23(1-3):3-25.
53. Van Het Hof K.H., West C.E., Weststrate J.A., et al. Dietary factors that affect the bioavailability of carotenoids. Journal of Nutrition 2000, 130(3):503.
54. Li E., Tso P. Vitamin A uptake from foods. Current Opinion in Lipidology 2003, 14(3):241-247.
55. Odeberg J.M., Lignell A., Pettersson A., et al. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. European Journal of Pharmaceutical Sciences 2003, 19(4):299-304.
56. Vertzoni M., Fotaki N., Kostewicz E., et al. Dissolution media simulating the intraluminal composition of the small intestine: physiological issues and practical aspects. Journal of Pharmacy and Pharmacology 2004, 56(4):453-462.
57. United States Pharmacopeia 31; General chapters: Physical Tests and Determinations; (711) Dissolution; In: USP31/NF26; 2009; p. 1578-1579.
58. Minekus M., Smeets-Peeters M.J.E., Bernalier A., et al. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Applied Microbiology and Biotechnology 1999, 53(1):108-114.
59. Kong F., Singh R.P. A model stomach system to investigate disintegration kinetics of solid foods during gastric digestion. Journal of Food Science 2008, 73(5):E202-E210.
60. Kong F., Singh R.P. Disintegration of solid foods in human stomach. Journal of Food Science 2008, 73(5):R67-R79.
61. Allen, L., De Benoist, B., Dary, O., Hurrell, R.F.; Guidelines on food fortification with micronutrients; World Health Organization and Food and Agriculture Organization of the United Nations, Geneva; 2006.
62. Lynch S. The precision of in vitro methods and algorithms for predicting the bioavailability of dietary iron. International Journal for Vitamin and Nutrition Research 2005, 75(6):436-445.
63. Lynch S. A comparison of methods for estimating the bioavailability of elemental iron food fortificants. Faseb Journal 2006, 20(4):A623.
64. Veber D.F., Johnson S.R., Cheng H.-Y., et al. Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry 2002, 45:2615-2623.
65. Thomas V.H., Bhattachar S., Hitchingham L., et al. The road map to oral bioavailability: an industrial perspective. Expert Opinion on Drug Metabolism and Toxicology 2006, 2(4):591-608.
66. Van Der Pijl P.C., Kies A.K., Ten Have G.A., et al. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008, 29(12):2196-2202.
67. Tai A., Fujinami Y., Matsumoto K., et al. Bioavailability of a series of novel acylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as an ascorbic acid supplement in rats and guinea pigs. Bioscience Biotechnology Biochemistry 2002, 66(8):1628-1634.
68. Hunt J.N., Smith J.L., Jiang C.L. Effect of meal volume and energy density on the gastric emptying of carbohydrates. Gastroenterology 1985, 89(6):1326-1330.
69. Hunt J.N., Stubbs D.F. The volume and energy content of meals as determinants of gastric emptying. Journal of Physiology 1975, 245:209-225.
70. Hunt J.N., Knox M.T. A relation between the chain length of fatty acids and the slowing of gastric emptying. Journal of Physiology 1968, 194:327-336.
71. Hunt J.N., Cash R., Newland P. Energy density of food, gastric emptying, and obesity. Lancet 1975, 2(7941):905-906.
72. Siegel J.A., Urbain J.L., Adler L.P., et al. Biphasic nature of gastric-emptying. Gut 1988, 29(1):85-89.
73. Pal A., Brasseur J.G., Abrahamsson B. A stomach road or 'Magenstrasse' for gastric emptying. Journal of Biomechanics 2007, 40(6):1202-1210.
74. Marciani L., Wickham M., Singh G., et al. Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction. American Journal of Physiology - Gastrointestinal and Liver Physiology 2007, 292(6):G1607-G1613.
75. Borel P. Factors affecting intestinal absorption of highly lipophilic food microconstituents (fat-soluble vitamins, carotenoids and phytosterols). Clinical Chemistry and Laboratory Medicine 2003, 41(8):979-994.
76. Doornbos A.M.E., Meynen E.M., Duchateau G.S.M.J.E., et al. Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 2006, 60(3):325-333.
77. Demonty I., Ras R., Van Der Knaap H.C.M., et al. Continuous dose-response relationship of the LDL-cholesterol lowering effect of phytosterol intake: a meta-analysis of randomised controlled trials. Journal of Nutrition 2008, 139:271-284.
78. Miller D.D., Schricker B.R., Rasmussen R.R., et al. An in-vitro method for estimation of iron availability from meals. American Journal of Clinical Nutrition 1981, 34(10):2248-2256.
79. Gueguen L., Pointillart A. The bioavailability of dietary calcium. Journal of the American College of Nutrition 2000, 19(2):119S-136S.
80. Graf B.A., Milbury P.E., Blumberg J.B. Flavonols, flavones, flavanones, and human health: epidemiological evidence. Journal of Medicinal Food 2005, 8(3):281-290.
81. Hu M. Commentary: Bioavailability of flavonoids and polyphenols: call to arms. Molecular Pharmaceutics 2007, 4(6):803-806.
82. Yang C.S., Sang S., Lambert J.D., et al. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Molecular Nutrition and Food Research 2008, 52(1):S139-S151.
83. Papadopoulou A., Frazier R.A. Characterization of protein-polyphenol interactions. Trends in Food Science and Technology 2004, 15:186-190.
84. Green R.J., Murphy A.S., Schulz B., et al. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Molecular Nutrition and Food Research 2007, 51(9):1152-1162.
85. Lorenz M., Jochmann N., Von Krosigk A., et al. Addition of milk prevents vascular protective effects of tea. European Heart Journal 2007, 28(2):219-223.